Overview

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Inhaled TPI 1100 in Healthy Volunteers

Status:
Withdrawn
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study will look at the safety and tolerability of TPI 1100 in healthy volunteers and look at pharmacodynamic (PD) effect on mRNA expression of PDE 4B/D & 7A in blood and in sputum.
Phase:
Phase 1
Details
Lead Sponsor:
Pharmaxis